Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Descriptive Pharmacoepidemiological Study of Patients Treated With Iressa

NCT01448187 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01448187
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01448187 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Descriptive Pharmacoepidemiological Study of Patients Treated With Iressa
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
January 31, 2012
Completion date
March 31, 2015
Enrollment
361 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer